Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other benign neoplasms of uterus
Summary
Other benign neoplasms of the uterus refer to non-cancerous growths originating from uterine tissue that are not classified under more specific benign neoplasm codes. These growths are localized, do not invade surrounding tissues, and do not spread to other parts of the body. They may include various histologic types of benign tumors affecting the uterine structure.
Causes
The exact causes of other benign neoplasms of the uterus are not fully understood, but they may arise from genetic mutations or abnormal cell proliferation in uterine tissue. Hormonal influences, particularly estrogen, are believed to play a role in the development of some uterine growths.
Risk Factors
- Hormonal imbalances (e.g., excess estrogen)
- Age (more common in reproductive or perimenopausal years)
- Prior uterine conditions or surgeries
- Family history of uterine neoplasms
- Obesity or metabolic syndrome
Symptoms
- Abnormal uterine bleeding (e.g., heavy or irregular periods)
- Pelvic pain or pressure
- Pelvic mass or enlargement
- Urinary frequency or retention
- Constipation or bowel changes
Diagnosis
Diagnosis typically involves a combination of clinical evaluation, imaging studies (e.g., ultrasound, MRI), and histopathologic examination of tissue samples. Pelvic exams may reveal abnormalities, and imaging helps characterize the size, location, and nature of the growth. Biopsy or surgical removal may be performed to confirm benignity.
Treatment Options
Treatment depends on the size, location, and symptoms of the neoplasm. Options may include:
- Watchful waiting for asymptomatic or small growths
- Medications (e.g., hormonal therapy) to manage symptoms
- Surgical removal (e.g., myomectomy, hysterectomy) for larger or symptomatic growths
- Minimally invasive procedures (e.g., hysteroscopy) for accessible lesions
Prognosis and Follow-Up
Prognosis is generally favorable, as these neoplasms are benign and do not metastasize. However, regular follow-up may be recommended to monitor for recurrence or changes. Symptomatic relief is often achieved with appropriate treatment, and most patients recover without long-term complications.
Complications
- Excessive bleeding (menorrhagia or metrorrhagia)
- Pelvic pain or discomfort
- Urinary or bowel obstruction (rare)
- Infertility (depending on location and size)
- Anemia from chronic blood loss
Lifestyle & Prevention
- Maintain a healthy weight to reduce hormonal imbalances
- Manage chronic conditions (e.g., diabetes, hypertension)
- Avoid unnecessary exposure to estrogen-like substances
- Attend routine gynecologic exams for early detection
- Discuss family history with a healthcare provider
When to Seek Professional Help
Seek medical attention if you experience:
- Sudden or severe pelvic pain
- Heavy or prolonged uterine bleeding
- Pelvic mass or noticeable enlargement
- Urinary or bowel changes (e.g., retention, constipation)
- Unexplained weight loss or fatigue
Tips for Medical Coders
When coding for D26 (Other benign neoplasms of uterus), ensure documentation specifies the type, location, and behavior of the neoplasm (e.g., benign, non-invasive). Verify that the neoplasm is not classified under a more specific code (e.g., leiomyoma) and that histopathology confirms benignity. Include details about symptoms, diagnostic methods, and treatment to support code assignment.
D26 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.